Trial Profile
Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2021
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary) ; Pimonidazole
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 24 Oct 2017 Status changed from recruiting to completed.
- 20 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.
- 21 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.